Bivalirudin versus heparin in patients undergoing percutaneous transcatheter aortic valve interventions: A systematic review and meta-analysis.
Pedro A VillablancaRasha Al-BawardyDivyanshu MohananeyCarola MarabotoMichael WeinreichTanush GuptaDavid F BricenoHarish RamakrishnaPublished in: Journal of interventional cardiology (2017)
In patient undergoing aortic valve interventions, no difference was seen between the use of bivalirudin and heparin as the procedural anticoagulant agent, except for a significant lower myocardial infarction events when bivalirudin was used. Further large randomized trials are needed to confirm current results.
Keyphrases
- aortic valve
- percutaneous coronary intervention
- venous thromboembolism
- transcatheter aortic valve replacement
- patients undergoing
- transcatheter aortic valve implantation
- aortic valve replacement
- aortic stenosis
- physical activity
- growth factor
- atrial fibrillation
- heart failure
- acute coronary syndrome
- coronary artery disease
- case report
- left ventricular
- ultrasound guided
- minimally invasive
- radiofrequency ablation
- ejection fraction